Professional Documents
Culture Documents
Interpretation Guide: OCT Angiography and Integrated Diagnostic Imaging
Interpretation Guide: OCT Angiography and Integrated Diagnostic Imaging
1 C
lick on the number icons to reveal
more information.
Click on the magnifying glass symbol to
see an enlarged version of the image.
X Click to close.
Multi-modality retinal imaging
with OCT Angiography (OCTA)
enables you to capture ultra-clear
images of retinal and choroidal
microvasculature in seconds.
3
Table of Contents
4
Branch Retinal Vein Occlusion (BRVO)
Patient History
53-year-old female
Summary
In contrast to a single
6x6 mm or 8x8 mm
scan, the AngioPlex ®
Montage—with up to
a 50-degree field of
view—is able to reveal 1
the extent of ischemia,
providing a more
complete clinical picture.
5
Branch Retinal Vein Occlusion (BRVO)
Patient History
53-year-old female
Summary
In contrast to a single
6x6 mm or 8x8 mm
scan, the AngioPlex ®
Montage—with up to
The 14x14 mm AngioPlex Montage,
X
a 50-degree field of
view—is able to reveal consisting of five 8x8 mm superficial scans,
1
reveals large areas of ischemia outside the
the extent of ischemia, posterior pole.
providing a more
complete clinical picture.
5
Branch Retinal Vein Occlusion (BRVO)
Patient History
53-year-old female
Summary
In contrast to a single
6x6 mm or 8x8 mm
scan, the AngioPlex ®
Montage—with up to
a 50-degree field of
view—is able to reveal 1
the extent of ischemia,
providing a more
complete clinical picture.
5
Neovascular Age-related Macular Degeneration (AMD)
Patient History
Patient presented with
1
a history of neovascular
AMD in the right eye,
which has been treated
with anti-VEGF.
More »
6
Neovascular Age-related Macular Degeneration (AMD)
Patient History X
Patient presented with Color fundus image shows small areas of RPE disruption and atrophy at
1
a history of neovascular the macula as well as areas of discoloration temporal to the macula.
AMD in the right eye,
which has been treated
with anti-VEGF.
More »
6
Neovascular AMD
Fundus autofluorescence
imaging (FAF) is
2
indicated in geographic
atrophy to document
the location and size of
disease.
More »
7
Neovascular AMD
Fundus autofluorescence X
imaging (FAF) is On this FAF Blue (FAF-B) image, autofluorescence at the macula is
2 obscured by naturally-occurring macular pigment, resulting in a dark
indicated in geographic area on the image.
atrophy to document
the location and size of
disease.
More »
7
Neovascular AMD
More »
8
Neovascular AMD
More »
8
Neovascular AMD
Summary
Integrated diagnostic
imaging allows the
clinician to quickly
monitor all aspects of the
disease, from accurately
documenting the location
and the extent of
geographic atrophy using
color and FAF images, to
monitoring for subretinal
fluid with OCT.
Summary X
The OCT B-scan shows irregular RPE contour; increased visibility of the
Integrated diagnostic
4 choroid can be seen in one area, indicating RPE atrophy. No subretinal
imaging allows the fluid is seen on B-scan.
clinician to quickly
monitor all aspects of the
disease, from accurately
documenting the location
and the extent of
geographic atrophy using
color and FAF images, to
monitoring for subretinal
fluid with OCT.
Summary
Integrated diagnostic X
imaging allows the Choriocapillaris OCTA slab overlaid onto the fundus image shows a
5
clinician to quickly Type-1 choroidal neovascular membrane beneath the fovea.
monitor all aspects of the
disease, from accurately
documenting the location
and the extent of
geographic atrophy using
color and FAF images, to
monitoring for subretinal
fluid with OCT.
Summary
Integrated diagnostic
imaging allows the
clinician to quickly
monitor all aspects of the
disease, from accurately
documenting the location
and the extent of
geographic atrophy using
color and FAF images, to
monitoring for subretinal
fluid with OCT.
Patient History
70-year-old male. Patient presented with complaints of decreased vision in the right eye.
More »
1 2 3
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
Name: Name: Name:
MacCube, Angio: 3x3 MacCube, Angio: 3x3 MacCube, Angio: 3x3
ID: 108 RETINA Exam Date: 11/9/2015 CZMI ID: 108 RETINA Exam Date: 11/23/2015 CZMI ID: 108 RETINA Exam Date: 7/22/2016 CZMI
DOB: 1/1/1948 Exam Time: 9:53 AM DOB: 1/1/1948 Exam Time: 9:17 AM DOB: 1/1/1948 Exam Time: 8:47 AM
Gender: Other Serial Number: 5000-4464 Gender: Other Serial Number: 5000-4429 Gender: Other Serial Number: 5000-4618
Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 8/10
Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS
ILM-RPE Thickness (µm) Fovea: Not found ILM-RPE Thickness (µm) Fovea: 256, 64 ILM-RPE Thickness (µm) Fovea: 244, 64
Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 %
Patient History
70-year-old male. Patient presented with complaints of decreased vision in the right eye.
More »
X
Exam 1: Macular cube scan
1 indicates fluid at the macula 2 3
Name: consistent with CSCR. Follow
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
MacCube, Angio: 3x3
Name:
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
MacCube, Angio: 3x3
Name:
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
MacCube, Angio: 3x3
ID:
DOB:
Gender: Other
up required.
108 RETINA
1/1/1948
Exam Date:
Exam Time:
Serial Number:
11/9/2015
9:53 AM
5000-4464
CZMI ID:
DOB:
Gender:
108 RETINA
1/1/1948
Other
Exam Date:
Exam Time:
Serial Number:
11/23/2015
9:17 AM
5000-4429
CZMI ID:
DOB:
Gender:
108 RETINA
1/1/1948
Other
Exam Date:
Exam Time:
Serial Number:
7/22/2016
8:47 AM
5000-4618
CZMI
Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 8/10
Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS
ILM-RPE Thickness (µm) Fovea: Not found ILM-RPE Thickness (µm) Fovea: 256, 64 ILM-RPE Thickness (µm) Fovea: 244, 64
Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 %
Patient History
70-year-old male. Patient presented with complaints of decreased vision in the right eye.
More »
1 2 3
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
Name: Name: Name:
MacCube, Angio: 3x3 MacCube, Angio: 3x3 MacCube, Angio: 3x3
ID: 108 RETINA Exam Date: 11/9/2015 CZMI ID: 108 RETINA Exam Date: 11/23/2015 CZMI ID: 108 RETINA Exam Date: 7/22/2016 CZMI
DOB: 1/1/1948 Exam Time: 9:53 AM DOB: 1/1/1948 Exam Time: 9:17 AM DOB: 1/1/1948 Exam Time: 8:47 AM
Gender: Other Serial Number: 5000-4464 Gender: Other Serial Number: 5000-4429 Gender: Other Serial Number: 5000-4618
Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 8/10
Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS
ILM-RPE Thickness (µm) Fovea: Not found ILM-RPE Thickness (µm) Fovea: 256, 64 ILM-RPE Thickness (µm) Fovea: 244, 64
Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 %
Patient History
70-year-old male. Patient presented with complaints of decreased vision in the right eye.
More »
X
Exam 2: Two weeks later,
1 2 patient reports improved vision. 3
Name:
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
MacCube, Angio: 3x3
Name: Macular cube scan shows fluid
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
MacCube, Angio: 3x3
Name:
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
MacCube, Angio: 3x3
ID:
DOB:
Gender:
108 RETINA
1/1/1948
Other
Exam Date:
Exam Time:
Serial Number:
11/9/2015
9:53 AM
5000-4464
CZMI ID:
DOB:
Gender:
is decreasing.
108 RETINA
1/1/1948
Other
Exam Date:
Exam Time:
Serial Number:
11/23/2015
9:17 AM
5000-4429
CZMI ID:
DOB:
Gender:
108 RETINA
1/1/1948
Other
Exam Date:
Exam Time:
Serial Number:
7/22/2016
8:47 AM
5000-4618
CZMI
Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 8/10
Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS
ILM-RPE Thickness (µm) Fovea: Not found ILM-RPE Thickness (µm) Fovea: 256, 64 ILM-RPE Thickness (µm) Fovea: 244, 64
Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 %
Patient History
70-year-old male. Patient presented with complaints of decreased vision in the right eye.
More »
1 2 3
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
Name: Name: Name:
MacCube, Angio: 3x3 MacCube, Angio: 3x3 MacCube, Angio: 3x3
ID: 108 RETINA Exam Date: 11/9/2015 CZMI ID: 108 RETINA Exam Date: 11/23/2015 CZMI ID: 108 RETINA Exam Date: 7/22/2016 CZMI
DOB: 1/1/1948 Exam Time: 9:53 AM DOB: 1/1/1948 Exam Time: 9:17 AM DOB: 1/1/1948 Exam Time: 8:47 AM
Gender: Other Serial Number: 5000-4464 Gender: Other Serial Number: 5000-4429 Gender: Other Serial Number: 5000-4618
Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 8/10
Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS
ILM-RPE Thickness (µm) Fovea: Not found ILM-RPE Thickness (µm) Fovea: 256, 64 ILM-RPE Thickness (µm) Fovea: 244, 64
Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 %
Patient History
70-year-old male. Patient presented with complaints of decreased vision in the right eye.
More »
Gender: Other Serial Number: 5000-4464 Gender: Other Serial Number: 5000-4429 Gender: Other Serial Number: 5000-4618
Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 9/10
small amount of remaining
Technician: Operator, Cirrus Signal Strength: 8/10
Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS
fluid.
ILM-RPE Thickness (µm) Fovea: Not found ILM-RPE Thickness (µm) Fovea: 256, 64 ILM-RPE Thickness (µm) Fovea: 244, 64
Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 %
Patient History
70-year-old male. Patient presented with complaints of decreased vision in the right eye.
More »
1 2 3
108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits- 108 RETINA - CSCR, CNV/SRF, (OD) 3 visits-
Name: Name: Name:
MacCube, Angio: 3x3 MacCube, Angio: 3x3 MacCube, Angio: 3x3
ID: 108 RETINA Exam Date: 11/9/2015 CZMI ID: 108 RETINA Exam Date: 11/23/2015 CZMI ID: 108 RETINA Exam Date: 7/22/2016 CZMI
DOB: 1/1/1948 Exam Time: 9:53 AM DOB: 1/1/1948 Exam Time: 9:17 AM DOB: 1/1/1948 Exam Time: 8:47 AM
Gender: Other Serial Number: 5000-4464 Gender: Other Serial Number: 5000-4429 Gender: Other Serial Number: 5000-4618
Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 9/10 Technician: Operator, Cirrus Signal Strength: 8/10
Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS Macula Thickness : Macular Cube 512x128 OD OS
ILM-RPE Thickness (µm) Fovea: Not found ILM-RPE Thickness (µm) Fovea: 256, 64 ILM-RPE Thickness (µm) Fovea: 244, 64
Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 % Overlay: ILM - RPE Transparency: 50 %
More »
11
CSC
X
The patient was 4 In standard practice, this case would not warrant FA. However, the patient
was scanned using OCTA, and a quick overview of the OCTA slab thumbnails
scanned using OCTA, identifies the slabs needing further evaluation.
and a quick overview
of the OCTA slab
thumbnails identifies
the slabs needing
further evaluation.
More »
11
CSC
More »
11
CSC
Summary 5
OCTA reveals the
presence of CNV in a
way that the standard
OCT B-scan or macular
cube scan cannot,
thereby elevating
confidence before a
patient is referred for
anti-VEGF injections.
12
CSC
X
Summary 5 RPE to RPE fit slab reveals CNV.
OCTA reveals the
presence of CNV in a
way that the standard
OCT B-scan or macular
cube scan cannot,
thereby elevating
confidence before a
patient is referred for
anti-VEGF injections.
12
CSC
Summary 5
OCTA reveals the
presence of CNV in a
way that the standard
OCT B-scan or macular
cube scan cannot,
thereby elevating
confidence before a
patient is referred for
anti-VEGF injections.
12
CSC
Summary 5
OCTA reveals the
presence of CNV in a
way that the standard
OCT B-scan or macular
cube scan cannot,
thereby elevating
confidence before a
patient is referred for
anti-VEGF injections.
12
Ischemic Diabetic Maculopathy
Patient History
This patient was first
imaged on a traditional
fundus camera.
More »
13
Ischemic Diabetic Maculopathy
Patient History
This patient was first
imaged on a traditional
fundus camera.
13
Ischemic Diabetic Maculopathy
Patient History
This patient was first
imaged on a traditional
fundus camera.
More »
2 Exam 4 (2016): During the fourth exam, the limited FoV of the color
X
fundus image suggests that the hemorrhages have improved. Whereas, the
FA image shows reperfusion of the macula.
13
Ischemic Diabetic Maculopathy
Summary
In such cases, OCTA
may be comparable to
FA and preferred since
OCTA is much quicker,
non-invasive and more
comfortable for the
patient.
14
Ischemic Diabetic Maculopathy
Summary
In such cases, OCTA
may be comparable to
FA and preferred since
OCTA is much quicker,
non-invasive and more
comfortable for the
patient.
14
Non-Proliferative Diabetic Retinopathy (NPDR)
Patient History
57-year-old, diabetic male,
presented with blurry vision, 1
worse in the right eye.
More »
OS
15
Non-Proliferative Diabetic Retinopathy (NPDR)
Patient History X
Because of the unexplained reduced VA, OCT was
57-year-old, diabetic male, performed to study the macula in more detail. Structural
presented with blurry vision, 1
B-scans showed trace DME OD, no DME OS. Foveal contour
worse in the right eye. was intact, and no other obvious disease was noted.
More »
OS
15
NPDR
Summary
OD OS
OCTA imaging revealed macular
ischemia in both eyes, which
explained the reduced visual acuity.
16
NPDR
Summary
OD OS
OCTA imaging revealed macular
ischemia in both eyes, which
explained the reduced visual acuity.
16
NPDR
Summary
OD OS
OCTA imaging revealed macular
ischemia in both eyes, which
explained the reduced visual acuity.
16
Exudative CNV
Patient History
A 52-year-old white male 1
was referred to the clinic
for retinal evaluation.
The patient complained
of sudden onset of
decreased central vision
in the right eye for the
past 2 days.
More »
17
Exudative CNV
Patient History X
Color fundus image reveals white subretinal lesion with surrounding
A 52-year-old white male 1 subretinal hemorrhage. OCT B-scan confirms location of lesion,
was referred to the clinic subretinal fluid is seen.
for retinal evaluation.
The patient complained
of sudden onset of
decreased central vision
in the right eye for the
past 2 days.
More »
17
Exudative CNV
Patient History
A 52-year-old white male 1
was referred to the clinic
for retinal evaluation.
The patient complained
of sudden onset of
decreased central vision
in the right eye for the
past 2 days.
More »
17
Exudative CNV
Summary
OCTA clearly reveals the
CNV lesion in greater
detail. In this case, FA
may not be needed to
make the diagnosis and
plan treatment.
As the technology
advances, OCTA may
complement FA exams 2
for certain diseases.
18
Exudative CNV
Summary
OCTA clearly reveals the
CNV lesion in greater
detail. In this case, FA
may not be needed to
make the diagnosis and
plan treatment.
As the technology
advances, OCTA may
complement FA exams 2
for certain diseases. Superficial retinal vasculature on OCTA mostly intact. However, X
further segmenting the avascular layer of the retina (outer retina)
reveals Type 2 CNV.
18
0297
Carl Zeiss Meditec, Inc. Carl Zeiss Meditec AG EN_31_200_0144I CZ-XII/2018 International Edition: Only for sales in selected countries.
5160 Hacienda Drive Goeschwitzer Strasse. 51-52 The contents of the brochure may differ from the current status of approval of the product or service
Dublin, CA 94568 07745 Jena offering in your country. Please contact our regional representatives for more information. Subject to
USA GERMANY change in design and scope of delivery and as a result of ongoing technical development.
© Carl Zeiss Meditec, Inc., 2018. All rights reserved.
www.zeiss.com/angioplex www.zeiss.com/angioplex
www.zeiss.com/med www.zeiss.com/med/contacts